Article
Repeated treatment with VEGF receptor inhibitors induces phenotypic changes in endothelial cells and pericytes in the rat retina.
Microvascular research - 1 Jan 2025
Nakano Ayuki, Kawada Takaaki, Morita Akane, Nakahara Tsutomu
Abstract excerpt
Abnormal ocular angiogenesis is a major cause of visual impairment and vision loss in neovascularization-related diseases. Currently, anti-vascular endothelial growth factor (VEGF) drugs are used to treat ocular neovascularization, but repeated injections are needed to maintain their therapeutic effects. However, repeated injection of anti-VEGF drugs may affect the retinal blood vessel phenotype and diminish...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
